<DOC>
	<DOCNO>NCT00618098</DOCNO>
	<brief_summary>The purpose study determine whether Octaplex ( human prothrombin complex concentrate ) reverse effect anticoagulant compare standard treatment fresh frozen plasma ( FFP ) .</brief_summary>
	<brief_title>Study Octaplex ( Human Prothrombin Complex Concentrate ) Fresh Frozen Plasma Patients Under Vitamin K Therapy Antagonist Needing Urgent Surgery Invasive Procedures</brief_title>
	<detailed_description>The primary objective study demonstrate efficacy Octaplex reversal agent patient vitamin K antagonist therapy need urgent surgery invasive procedure clinically inferior FFP . The secondary objective study investigate safety tolerability Octaplex compare FFP patient vitamin K antagonist therapy need urgent surgery invasive procedure .</detailed_description>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin K</mesh_term>
	<mesh_term>Thrombin</mesh_term>
	<criteria>Male female patient least 18 year age . Patients receive oral anticoagulation coumadin warfarin derive agent . Patients need urgent surgery invasive procedure 8 hour admission identification patient currently hospitalize , oral parenteral vitamin K therapy deem slow action reversal coumadin warfarin anticoagulant effect . Patients international normalize ratio ( INR ) 2.0 . Patients give write informed consent write informed consent obtain patient 's legal representative behalf . Patients able willing comply procedure lay study protocol . In case unconscious and/or incapacitate patient , willingness patient 's legal representative patient undergo procedure lay study protocol . Patients life expectancy le 48 hour ( eg , patient Glasgow Coma Scale ( GCS ) equal 3 head abbreviate injury score ( AIS ) 6 , patient require continuous inotropic pressor support , patient status postcardiac arrest ) . Patients history within last 6 month disseminate intravascular coagulation ( DIC ) , hyperfibrinolysis . Patients know congenital coagulation disorder . Patients know antiphospholipid antibody syndrome know lupus anticoagulant antibody . Patients present past specific factor inhibitor activity . Patients thrombocytopenia &lt; 80,000 history heparin induce thrombocytopenia ( HIT ) . Patients receive heparin type noncoumadin warfarin anticoagulant immediately prior and/or intend give within first 1 hour postinfusion . Patients receive vitamin K 3 hour prior infusion study drug . Patients history hypersensitivity plasmaderived product . Pregnant nursing woman . Patients participate another clinical treatment study currently past 1 month prior study inclusion . Patients previously enrol study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>anticoagulant reversal</keyword>
	<keyword>urgent surgery</keyword>
	<keyword>invasive procedure</keyword>
	<keyword>vitamin K</keyword>
	<keyword>prothrombin complex concentrate</keyword>
</DOC>